Target intelligence / Profile preview

Periodic tryptophan protein 2 homolog (PWP2)

Target
PWP2
Molecular classification
Ribosome biogenesis factor, WD repeat domain-containing protein, Nucleolar protein, Small subunit processome component
01

Overview

Periodic tryptophan protein 2 homolog (PWP2) is a conserved, nucleolar protein that is an essential component of the small subunit (SSU) processome, the primary precursor of the small eukaryotic ribosomal subunit. PWP2 functions within the UtpB subcomplex and plays a central role in the biogenesis and assembly of the 18S rRNA-containing small ribosomal subunit by facilitating rRNA folding, modification, and processing events. It is classified as a WD-repeat-containing protein, which enables interactions with RNA and numerous protein partners within the nucleolus. Genetic disruption of PWP2 affects ribosome assembly and leads to cellular and developmental defects. No current drugs are known to target PWP2, and it is not considered a therapeutic target as of 2025.

Other names
EHOC-17PWP2HUTP1small subunit processome componentPWP2 periodic tryptophan protein homolog (yeast)UTPB SSU processome subunit
02

Mechanism of action

Not applicable; PWP2 is not an established therapeutic target

03

Biological functions

Ribosomal small subunit biogenesisAssembly of small subunit processomeRNA bindingPart of the rRNA processing pathwayInvolved in nucleolar ribonucleoprotein complex formation
04

Disease associations

Holoprosencephaly 1Carpal tunnel syndrome 2No direct role in cancer, inflammation, or other major diseases established as of now
05

Safety considerations

None reported in the context of therapeuticsPotential developmental impact via ribosome biogenesis

Beyond the preview

Go deeper on Periodic tryptophan protein 2 homolog (PWP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Periodic tryptophan protein 2 homolog (PWP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call